Skip to content
2000
Volume 14, Issue 2
  • ISSN: 1574-8863
  • E-ISSN: 2212-3911

Abstract

Background: Selective Serotonin Reuptake Inhibitors (SSRIs) are the first-line treatments for various psychiatric disorders. SSRIs offer an improved side effect profile compared to older treatments, which improves patients’ adherence and quality of life. Case Report: Here we discuss a case of an uncommon, but a distressing side effect of citalopram. A 76-year old woman was referred to the psychiatry clinic for bizarre behavior. The patient was diagnosed with behavioral variant frontotemporal dementia and was started on citalopram 20 mg and aripiprazole 5 mg daily. At 3.5 months the patient complained of diffuse hair thinning on her scalp. Citalopram was considered the offending agent and was discontinued. Within a few months, the patient regained most of her hair. Although drug-induced alopecia is common among other SSRIs, it is relatively rare with citalopram. Results and Conclusion: Early recognition, withdrawal of offending agent, and reassurance to the patient that hair loss is reversible can help alleviate patient distress and avoid relapse.

Loading

Article metrics loading...

/content/journals/cds/10.2174/1574886314666190215115857
2019-07-01
2025-07-11
Loading full text...

Full text loading...

/content/journals/cds/10.2174/1574886314666190215115857
Loading

  • Article Type:
    Case Report
Keyword(s): adverse drug reactions; Alopecia; citalopram; Fluoxetine; SSRIs; VIGIBASE
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test